FDA approves additional Covid booster for high-risk individuals and seniors.
TL;DR Summary
The FDA has authorized a second updated booster shot against Covid-19 for people who are at least 65 years old or immune-compromised, designed to bolster protection for the most vulnerable Americans. The bivalent booster targets omicron subvariants BA.4 and BA.5 as well as the original coronavirus. Vaccine advisers to the Centers for Disease Control and Prevention are scheduled to meet Wednesday to discuss the second booster, and CDC Director Rochelle Walensky is expected to sign off quickly. The updated shot will be free of charge, regardless of insurance coverage, because the government has an ample supply.
- FDA okays second omicron booster for people at high risk from covid The Washington Post
- F.D.A. Authorizes Another Covid Booster Shot for People Over 65 The New York Times
- Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S. The Wall Street Journal
- FDA authorizes 2nd dose of updated Covid booster for older adults NBC News
- Extra spring COVID booster cleared for certain Americans The Associated Press
Reading Insights
Total Reads
0
Unique Readers
18
Time Saved
5 min
vs 6 min read
Condensed
90%
1,010 → 96 words
Want the full story? Read the original article
Read on The Washington Post